MEDICINE: High Volume a Must; Adoption Becoming Norm
In San Diego hospitals, robots are on the rise, judging by splashy marketing and an increase in robotic surgery cases, per data obtained by the San Diego Business Journal.
Damien McDevitt has joined Carlsbad’s Ionis Pharmaceuticals as chief business officer.
A new UC San Diego center is targeting an unmet need: parasitic infections hurting poor and underserved communities.
PHARMA: Scientist.com Doubles Revenue to $50M
Scientist.com reported $50.27 million in 2017 revenue, a whopping increase from $23.07 million in 2016 and $6 million in 2015.
A shareholder of San Diego-based biotech Senomyx is pushing for the company’s chairman to resign, an immediate company sale and a new board seat.
The San Diego/Imperial Chapter of the Alzheimer’s Association awarded a three-year, $175,000 fellowship to a UC San Diego researcher on a quest to determine the earliest indications of Alzheimer’s disease.
PHARMA: They’re Part of Growing Biotech Relationship
In San Diego, the last decade gave rise to biotechs farming out work to contract research organizations, or CROs. It’s an industry increasingly colored by China.
San Diego biotech Metacrine, which is working on drugs for liver, metabolic and gastrointestinal diseases, last week closed a $65 million Series C round.
San Diego biotech Trovagene closed an $18 million public offering on June 12.
A well-known researcher at Salk Institute for Biological Studies resigned on June 11 after an investigation into his conduct.
San Diego-based Vical is terminating its herpes vaccine candidate following not-so-great mid-stage clinical trial results.
HEALTH: Brings Opportunities in Billing, Records and Analytics
ResMed’s acquisition of Healthcarefirst looks to tap into a growing trend: digitally connected devices for those who prefer medical care at home.
MEDICINE: Diversity Is a Must, Both in Patients and Studies
Artemis Institute for Clinical Research helps to advance groundbreaking treatments. A challenge in this line of work: getting people in the door.
A COO/CFO gig at Carlsbad’s Oska Wellness belongs to Bob Ohlweiler, who has held positions with Hewlett-Packard, Kodak, Yahoo!, Razer, and MusicMatch.
Craig Venter is retiring as the CEO of San Diego-based Human Longevity Inc., about five months after reassuming the role.
Net proceeds from Pfenex’s common stock offering amounted to $39.4 million, it was recently announced.
San Diego-based trade group Biocom appointed four new board members. The new members, announced May 31, play major roles in the region’s life sciences ecosystem:
San Diego-based ResMed will acquire HEALTHCAREfirst, which specializes in software for home health and hospice agencies.
Once-ousted CEO Joseph Payne is back leading Arcturus Therapeutics. Even he saw a return as a longshot.
The California Life Sciences Association has a new board member: Jared Watkin, the senior vice president of Diabetes Care at Abbott Laboratories.
Former Arcturus CEO Joseph Payne appears to have prevailed in a fight for control of the company.
PHARMA: Skipping Partnerships Can Build Profits and Skill Sets
Several San Diego biotechs — including Neurocrine and Arena Pharmaceuticals — are bucking the norm by handling drug commercialization themselves.
J. Craig Venter is retiring as the CEO of San Diego-based Human Longevity, Inc., about five months after reassuming the role.
BIOTECH: From Cancer to Concussions, Efforts Change Cost, Course of Treatments
Banyan Biomarkers hit a milestone in February when its blood test for traumatic brain injuries won U.S. Food and Drug Administration approval.
FINANCE: Co. Doesn’t Expect Any Change to U.S. Tax Assessment
San Diego-based ResMed is challenging an Australian Taxation Office assessment saying the company owes $190.1 million.
A proxy fight between Arcturus Therapeutics’ board and former CEO will play out at a newly set June meeting.
San Diego-based Bloom Science, which emerged May 24, is drawing upon gut bacteria to develop medicines.
San Diego biotech Evofem Biosciences, which focuses on women’s sexual and reproductive health, announced a public stock offering on May 22.
San Diego’s AristaMD has hired Adam Darkins, known for his work with the Department of Veterans Affairs, as the company's chief strategy officer.
The Gary and Mary West Emergency Department at UC San Diego Health last week was accredited as a geriatric emergency department, the first such accreditation in California and one of only eight nationally.
San Diego-based Cidara Therapeutics and Rutgers University were awarded a $5.5 million grant to research and further develop an immunotherapy platform.
HEALTH: Drug Treats Seizures; Co. Prepares For Commercialization
A plant-derived cannabis medicine is poised to be the first of its kind to win U.S. Food and Drug Administration approval. A winner of the expected greenlight: Carlsbad’s Greenwich Biosciences.
PHARMA: Co. Transforms After Weight-Loss Flop
Arena Pharmaceuticals’ weight-loss drug flopped a few years ago, signaling a bleak future. That is, if you ignored Arena’s shelved compounds.
Accelerator Life Science Partners, a life science investment and management firm, has opened a San Diego office at The Alexandria at Torrey Pines.
Former film executive Sherry Lansing, who led Paramount and Fox motion picture studios, has been named to The Scripps Research Institute board.
BIOTECH: Acquisition Moves Co. Toward Push-Button Process for Analysis
Illumina bought data processing specialist Edico Genome for $100 million as part of a bid to expand genomics testing in research and health care.
Genomics giant Illumina has purchased Edico Genome, adding a processing platform to Illumina’s portfolio.
San Diego-based MEI Pharma reported on May 14 raising $75 million through a private placement, led by Vivo Capital and CAM Capital.
San Diego biotech Cidara Therapeutics reported a net loss of $16.7 million in the first quarter, compared to a $13.14 million net loss in the first quarter of last year.
PHARMA: Partnerships and Promising Pipeline Boost Co.
When Stanley Crooke formed Ionis Pharmaceuticals in 1989, he saw the venture as a longshot. He told investors as much.
San Diego-based Escient Pharmaceuticals launched with a $40 million Series A round, which will go toward a pipeline of novel drugs.
San Diego-based Neurana Pharmaceuticals raised $60 million in Series A financing for a relaxant that treats acute, painful muscle spasms.
Solana Beach-based Luna DNA raised $2 million in a new round of funding, led by Illumina Ventures and Arch Venture Partners, it was announced May 8.
FINANCE: Q1 Delivers Record Investment Locally and Nationally
Investment in San Diego-based life sciences companies hit a record high $417.9 million in quarter one of 2018, according to an April CBRE Group Inc. report.
The Scripps Translational Science Institute (STSI) was awarded $34 million in renewed funding to advance genomic and digital technologies in clinical care.
AMN Healthcare reported $522 million in quarter one revenue, up 6 percent year over year, fueled by higher-than-expected staffing needs.
TRADE: S.D. Cos. Able to Avoid Some of the Complexities
San Diego biotechs are inking deals with Chinese firms to tap into China’s ever-growing demand for groundbreaking drugs.
San Diego-based Dexcom reported a 30 percent year-over-year revenue increase in quarter one results due a sharp increase in international sales.
NuVasive reported $260.5 million in quarter one results, a 4.6 percent year-over year increase, with its core U.S. hardware business showing solid growth.
San Diego-based Synthorx — formed around synthetic biology for novel protein therapies — raised $63 million in a Series C round.